Blood Transfusion (Blood Transfusions)

Subscribe to Selected New Research on Blood Transfusion

8851 relevant articles (249 outcomes, 537 trials/studies) found for this Therapy

Description: The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed)

Also Known As:

Blood Transfusions; Transfusion, Blood; Transfusions, Blood

Relationship Network

Therapy Context: Research Results

Therapeutics: 6127

Biological Therapy: 935

Blood Transfusion: 8851

Plasma Exchange: 2242

Autologous Blood Transfusion: 518

Intrauterine Blood Transfusion: 290

Blood Component Transfusion: 28

Whole Blood Exchange Transfusion: 5

Experts

1.	Rao, Sunil V: 6 articles (02/2008 - 10/2004)
2.	Bhattacharya, N: 6 articles (01/2006 - 01/2006)
3.	Centers for Disease Control and Prevention (CDC): 6 articles (11/2002 - 09/2002)
4.	Vamvakas, E C: 5 articles (10/2007 - 07/2000)
5.	Harrington, Robert A: 4 articles (02/2008 - 10/2004)
6.	Granger, Christopher B: 4 articles (02/2008 - 10/2004)
7.	Califf, Robert M: 4 articles (02/2008 - 10/2004)
8.	Buchanan, George R: 4 articles (11/2006 - 03/2002)
9.	Corwin, Howard L: 4 articles (02/2004 - 08/2003)
10.	Napolitano, Lena M: 4 articles (02/2004 - 05/2003)

Related Diseases

1.	Anemia 04/01/1999 - "Much of the increase in the patient's Hct vanishes at higher blood losses, and this therapy is most effective with blood loss of <4000 mL. EPO therapy alone may be most effectively used in patients with mild anemia who are undergoing routine surgical procedures that commonly require blood transfusion." 09/01/2005 - "Corticosteroid therapy and rinsed blood transfusion were very effective for anemia. " 03/01/1990 - "If proven effective in treating anemia in premature babies, r-HuEPO will be responsible for a major reduction in the use of blood transfusions in clinical neonatology. " 04/01/2003 - "It has been assessed for the treatment of chemotherapy related anemia in NHL, myeloma and CLL with a significant reduction of blood transfusions and prevention of grade 3-4 anemia in 51% of patients. " 12/01/1996 - "A good outcome (neither recurrence of anemia nor blood transfusion requirements) was observed in 12 patients. " Order ALL the reference details at left...
2.	Hemorrhage 12/01/2006 - "CONCLUSIONS: Use of ultrafiltration is associated with a significant reduction in postoperative blood transfusions as well as reduced bleeding in adults undergoing cardiac surgery. " 04/01/2005 - "Bleeding requiring blood transfusion was significantly greater in the multiple access group. " 08/01/1997 - "For Grade 3 bleeding, three patients responded without medication following blood transfusion only, while with multiple coagulations and medication 12 of 16 patients improved to < or = Grade 1. Multivariate analysis demonstrates that dose is the only significant factor associated with Grade 2 (p = 0.01) or Grade 3 (p = 0.01) rectal bleeding. " 08/01/1994 - "The amount of postoperative bleeding was significantly greater in 14 cases with blood transfusion and the amount of intraoperative bleeding was not significantly greater in blood transfusion cases. " 09/01/1993 - "The introduction of the injection therapy in patients who were actively bleeding resulted in a significant reduction of the emergency operation rate (70.2% v. 12.8%; P < 0.001), mortality rate (21.3% v. 8.5%; P < 0.05 and blood transfusion requirements (4,220 +/- 1,840 ml v. 1,980 +/- 980 ml; P < 0.05). " Order ALL the reference details at left...
3.	Infection 06/01/1993 - "The risk of infection by blood transfusions contaminated with the human immunodeficiency virus (HIV) and/or the hepatitis C virus (HCV) was dramatically reduced after the introduction of blood donor screening using specific and sensitive 2nd- or 3rd-generation enzyme immunoassays for virus antibody detection. " 11/01/1990 - "Successful use of exchange blood transfusion as a therapeutic adjunct for this infection was first reported in 1974, although the efficacy of this procedure has not been established by randomized, controlled trials. " 02/17/1998 - "CONCLUSIONS: In cardiac surgery patients, especially when more than three blood transfusions are required, leukocyte depletion by filtration results in a significant reduction of the postoperative mortality that can only partially be explained by the higher incidence of postoperative infections in the PC group." 09/01/1990 - "Modifications in donor screening and the introduction of laboratory testing of donated blood for anti-HIV-1 and anti-HTLV-I have resulted in a significant reduction in the risks of retroviral infections from blood transfusion. " 08/01/1952 - "In the light of improved means of combating infection, better and safer anesthesia, the ready availability of blood transfusion, and less traumatic delivery, reasons formerly advanced in opposition to operations at the time of parturition for repair of preexisting lesions of the pelvic floor are now less formidable than they were in the past. " Order ALL the reference details at left...
4.	Neoplasms (Cancer) 10/01/2002 - "OR time, estimated blood loss, blood transfusions, tumor size, time in intensive care, and post-OR hospitalization were all significantly greater in patients with vascular complications. " 05/01/1993 - "Transfusion-induced immunosuppression has long been known to be beneficial for organ transplantation patients, but recent retrospective studies suggest that blood transfusions may be detrimental for patients with cancer. " 03/01/2006 - "Multivariate analysis showed that pT, grading, preoperative CEA level, gender, and site of the tumor along the rectum, the number of blood transfusion and the age group of more than 65 years are independent risk factors for both overall survival and disease-free interval. " 11/01/1989 - "For the patients with stage I cancer, perioperative blood transfusion resulted in a worse disease-free and overall survival (p = 0.05 and 0.02, respectively), which was particularly evident for those patients who received more than 1 unit. " 09/01/1997 - "Surgical resection remains the mainstay of treatment for patients with hepatic tumors, despite the associated morbidity including the need for blood transfusion. " Order ALL the reference details at left...
5.	Wounds and Injuries (Trauma) 05/01/2005 - "While other techniques are being developed, we think that autologous blood collection and blood reinfusion from wound drainage are effective in reducing the need for homologous blood transfusion; this is important because of the potential risk of reactions, disease transmission and limited blood bank resources." 05/01/2002 - "The rest received an operative management but in comparison had more severe liver injury scales, higher incidence of associated injuries, significantly greater blood transfusion requirements, longer hospital stay and a mortality rate of 67%. " 11/01/1986 - "A spectrum of blunt splenic trauma, as manifested by the degree of associated injuries (Injury Severity Scores), hemodynamic status, and blood transfusion requirements, was identified and permitted application of a rational selective management program that proved safe and effective for all age groups. " 08/01/2009 - "CONCLUSIONS: This study represents the largest series comparing trauma patients who received either LR or standard blood transfusions. " 05/01/2009 - "Studies were selected for inclusion if they included trauma patients who required blood transfusion. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Erythropoietin
2.	Hemoglobins (Hemoglobin)
3.	Antibodies
4.	Anti-Bacterial Agents (Antibiotics)
5.	Aprotinin (Trasylol)
6.	Tranexamic Acid (AMCA)
7.	Iron
8.	Epoetin Alfa (Epogen)
9.	Hepatitis B Surface Antigens (HBsAg)
10.	Heparin (Liquaemin)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Blood Transfusion (Blood Transfusions)
3.	Splenectomy
4.	Homologous Transplantation (Allograft)
5.	Arthroplasty

Best Treatments:
Research Summary Report
on Anemia

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 1062 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>